 |
|
|
Corium International, Inc. is a leader in applying advanced transdermal delivery systems and related technologies to address unmet medical needs. We have developed two highly differentiated state of the art transdermal technologies:
-
MicroCor®, a biodegradable microstructure patch technology for active delivery of proteins, peptides and vaccines—large molecules that require active transport through the skin
-
Corplex™, a novel adhesive system and patch technology for delivery of small molecules that may otherwise be difficult to formulate and deliver
With a team that includes the innovators of many of the market-leading transdermal products, Corium combines great technologies
with a strong track record of successfully designing, developing and producing therapeutic products.
|
|
|
|
|
-
September 4-6, 2013
Bobby Singh, Chief Technology Officer and VP, R&D, will present a program, Simplifying Vaccine Administration with Transdermal MicroCor®, at the Skin Vaccination Summit 2013, in Seattle, Washington.
-
June 5-7, 2013
Bobby Singh, Chief Technology Officer and VP, R&D, will present a program, Next Generation Transdermal Technologies for Needle-free Delivery of Biologicals, at the World Pharma Congress, Philadelphia, Pennsylvania
-
April 17, 2013
Bobby Singh, Chief Technology Officer and VP, R&D, will present a seminar, MicroCor® - Needle Free Transdermal Technology for Vaccine Delivery, at the World Vaccine Congress & Expo, National Harbor, Maryland.
-
March 21, 2013
Bobby Singh, Chief Technology Officer and VP, R&D, made a poster presentation, High Adhesive 6% Strips and Tooth Color by Arch, at the International Association for Dental Research General Session and Exhibition in Seattle, Washington.
-
February 8, 2013
Peter Staple, President and CEO at Corium, presented a program, Patient First Approach to Delivery of Biologics at the Drug Delivery Partnership meeting in San Diego, California.
|
|
|
|
|
|
